4.6

CiteScore

2.2

Impact Factor
  • ISSN 1674-8301
  • CN 32-1810/R
Ravi Prakash Rao, Ansima Singh, Arun K Jain, Bhartu Parsharthi Srinivasan. Dual therapy of rosiglitazone/pioglitazone with glimepiride on diabetic nephropathy in experimentally induced type 2 diabetes rats[J]. The Journal of Biomedical Research, 2011, 25(6): 411-417. DOI: 10.1016/S1674-8301(11)60054-7
Citation: Ravi Prakash Rao, Ansima Singh, Arun K Jain, Bhartu Parsharthi Srinivasan. Dual therapy of rosiglitazone/pioglitazone with glimepiride on diabetic nephropathy in experimentally induced type 2 diabetes rats[J]. The Journal of Biomedical Research, 2011, 25(6): 411-417. DOI: 10.1016/S1674-8301(11)60054-7

Dual therapy of rosiglitazone/pioglitazone with glimepiride on diabetic nephropathy in experimentally induced type 2 diabetes rats

More Information
  • Received Date: June 14, 2011
  • Diabetic nephropathy is a major cause of end-stage renal disease (ESRD) in the general population. It is es-timated that diabetic nephropathy will eventually develop in about 40% of all patients with diabetes; therefore, prevention is critical for delaying the development and progression of diabetic kidney disease. Despite extensive efforts, medical advances are still not successful enough to prevent the progression of the disease. In the present study, we focused on the comparison of combination therapies and whether they offered additional renopro-tection. Type 2 diabetes mellitus was induced by intraperitoneally administering streptozotocin (90 mg/kg) in neonatal rats and then these rats were treated with rosiglitazone (1.0 mg/kg) in combination with glimepiride (0.5 mg/kg) or with pioglitazone (2.5 mg/kg) in combination with glimepiride (0.5 mg/kg). Diabetic nephropathy markers were evaluated by biochemical and ELISA kits and renal structural changes were examined by light mi-croscopy and transmission electron microscopy. Results show that the combination of pioglitazone with glimepir-ide is more effective in amelioration of diabetic nephropathy than rosiglitazone with glimepiride drug therapy due to glycemic control, suppressing albumin excretion rate, total protein excretion rate and augmented TNF-a signal-ing during the development of streptozotocin induced type 2 diabetic nephropathy.
  • Related Articles

    [1]Izzatullo Ziyoyiddin o`g`li Abdullaev, Ulugbek Gapparjanovich Gayibov, Sirojiddin Zoirovich Omonturdiev, Sobirova Fotima Azamjonovna, Sabina Narimanovna Gayibova, Takhir Fatikhovich Aripov. Molecular pathways in cardiovascular disease under hypoxia: Mechanisms, biomarkers, and therapeutic targets[J]. The Journal of Biomedical Research. DOI: 10.7555/JBR.38.20240387
    [2]Xue Zhang, Dan Zhang, Lei Huo, Xin Zhou, Jia Zhang, Min Li, Dongming Su, Peng Sun, Fang Chen, Xiubin Liang. Upregulation of α-ENaC induces pancreatic β-cell dysfunction, ER stress, and SIRT2 degradation[J]. The Journal of Biomedical Research, 2024, 38(3): 241-255. DOI: 10.7555/JBR.37.20230128
    [3]Pengxi Shi, Ao Tan, Yuanyuan Ma, Lingli Que, Chuanfu Li, Yongfeng Shao, Haoliang Sun, Yuehua Li, Jiantao Li. MicroRNA-19a-3p augments TGF-β1-induced cardiac fibroblast activation via targeting BAMBI[J]. The Journal of Biomedical Research. DOI: 10.7555/JBR.37.20230313
    [4]Cui Qi, Jiaqi Zhang, Yuanyuan Wang, Mingyan Lin, Jun Gao, Haiying Lu. Valproic acid enhances neurosphere formation in cultured rat embryonic cortical cells through TGFβ1 signaling[J]. The Journal of Biomedical Research, 2022, 36(2): 127-140. DOI: 10.7555/JBR.36.20210109
    [5]Nolan B. Ayers, Chenming Sun, Shi-You Chen. Transforming growth factor-β signaling in systemic sclerosis[J]. The Journal of Biomedical Research, 2018, 32(1): 3-12. DOI: 10.7555/JBR.31.20170034
    [6]Ankit Mahajan, Swarkar Sharma, Manoj K. Dhar, Rameshwar N.K. Bamezai. Risk factors of type 2 diabetes in population of Jammu and Kashmir, India[J]. The Journal of Biomedical Research, 2013, 27(5): 372-379. DOI: 10.7555/JBR.27.20130043
    [7]Guanhua Su, Kun Liu, Yan Wang, Jue Wang, Xiaowei Li, Wenzhu Li, Yuhua Liao, Zhaohui Wang. Fibrinogen-like protein 2 expression correlates with microthrombosis in rats with type 2 diabetic nephropathy[J]. The Journal of Biomedical Research, 2011, 25(2): 120-127. DOI: 10.1016/S1674-8301(11)60015-8
    [8]Juan Du, Hui Shi, Ying Lu, Wencong Du, Yuanyuan Cao, Qian Li, Jianhua Ma, Xinhua Ye, Jinluo Cheng, Xiaofang Yu, Yanqin Gao, Ling Zhou. Tagging single nucleotide polymorphisms in the PPAR-γ and RXR-α gene and type 2 diabetes risk: a case-control study of a Chinese Han population[J]. The Journal of Biomedical Research, 2011, 25(1): 33-41. DOI: 10.1016/S1674-8301(11)60004-3
    [9]Haiyang?Qian, Zhifang?Song, Meilin?Wang, Xiaomin?Jia, Aiping?Li, Ye?Yang, Lianlian?Shen, Shasha?Wang, Chunhui?Ni, Jianwei?Zhou. Association of transforming growth factor-β1 gene variants with risk of coal workers pneumoconiosis[J]. The Journal of Biomedical Research, 2010, 24(4): 270-276. DOI: 10.1016/S1674-8301(10)60038-3
    [10]Wei Qin, Xin Chen, Peisheng Liu. Inhibition of TGF-β1 by eNOS gene transfer provides cardiac protection after myocardial infarction[J]. The Journal of Biomedical Research, 2010, 24(2): 145-152.

Catalog

    Article Metrics

    Article views (8416) PDF downloads (4725) Cited by()
    Related

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return